Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by bionicjoeon Jun 20, 2019 10:54am
78 Views
Post# 29844417

RE:RE:This silence is really weird.

RE:RE:This silence is really weird.
barolo19 wrote:
Jonzeeee wrote:
no updates on anything. They couldn't even bother to let shareholders know how Polaris is going or anything else they are working on to break the silence. Really odd choices by management.

For a company that is the behemoth of cannabis in 24 countries and 5 continents seems very odd on the news front? You would think with all these irons in the fire there would be some sort of development somewhere.


The market is no longer impressed about anything that does not directly relate to quarterly revenue beats or a significant JV partner deal. Everything else is moot. The market is still waiting to see the huge revenue numbers it has been promised.
Bullboard Posts